ANDYA; James
Patent Applications and Registrations
Patent applications and USPTO patent grants for ANDYA; James.The latest application filed is for "anti-ox40 antibodies and methods of use".
- ANDYA; James - Millbrae CA
- ANDYA; James - South San Francisco CA
- Andya; James - Milbrae CA
| Patent | Date |
|---|---|
| Anti-ox40 Antibodies And Methods Of Use App 20210009705 - DU; Changchun ; et al. | 2021-01-14 |
| Anti-OX40 antibodies and methods of use Grant 10,730,951 - Du , et al. | 2020-08-04 |
| Antibody Formulations App 20200179515 - ANDYA; JAMES ; et al. | 2020-06-11 |
| Combination Therapy Comprising Anti-angiogenesis Agents And Ox40 Binding Agonists App 20190062444 - Walsh; Kevin ; et al. | 2019-02-28 |
| Anti-ox40 Antibodies And Methods Of Use App 20180230227 - DU; Changchun ; et al. | 2018-08-16 |
| Antibody Formulations App 20180221488 - ANDYA; JAMES ; et al. | 2018-08-09 |
| Anti-OX40 antibodies and methods of use Grant 9,975,957 - Du , et al. May 22, 2 | 2018-05-22 |
| Combination Therapy Comprising Anti-angiogenesis Agents And Ox40 Binding Agonists App 20170015755 - WALSH; Kevin ; et al. | 2017-01-19 |
| Protein formulation Grant 9,283,273 - Andya , et al. March 15, 2 | 2016-03-15 |
| Treating a mammal with a formulation comprising an antibody which binds IgE Grant 9,180,189 - Andya , et al. November 10, 2 | 2015-11-10 |
| Anti-ox40 Antibodies And Methods Of Use App 20150307617 - DU; Changchun ; et al. | 2015-10-29 |
| Antibody Formulations App 20150196642 - ANDYA; JAMES ; et al. | 2015-07-16 |
| Method of treating cancer with a pharmaceutical formulation comprising a HER2 antibody Grant 9,017,671 - Andya , et al. April 28, 2 | 2015-04-28 |
| Protein Formulation App 20130224185 - Andya; James ; et al. | 2013-08-29 |
| Antibody Formulations App 20130071384 - ANDYA; JAMES ; et al. | 2013-03-21 |
| Antibody formulations Grant 8,372,396 - Andya , et al. February 12, 2 | 2013-02-12 |
| Protein Formulation App 20110236383 - Andya; James ; et al. | 2011-09-29 |
| Protein Formulation App 20100158899 - Andya; James ; et al. | 2010-06-24 |
| Protein formulation Grant 7,682,609 - Andya , et al. March 23, 2 | 2010-03-23 |
| Antibody Formulations App 20100015157 - Andya; James ; et al. | 2010-01-21 |
| Protein formulation App 20060275306 - Andya; James ; et al. | 2006-12-07 |
| Protein formulation Grant 7,060,268 - Andya , et al. June 13, 2 | 2006-06-13 |
| Treating a mammal with a formulation comprising an antibody which binds IgE App 20060099201 - Andya; James ; et al. | 2006-05-11 |
| Antibody formulations App 20060088523 - Andya; James ; et al. | 2006-04-27 |
| Protein formulation Grant 6,685,940 - Andya , et al. February 3, 2 | 2004-02-03 |
| Protein formulation App 20030202972 - Andya, James ; et al. | 2003-10-30 |
| Protein formulation App 20010014326 - Andya, James ; et al. | 2001-08-16 |
| Protein formulation Grant 6,267,958 - Andya , et al. July 31, 2 | 2001-07-31 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 